Fig. 1From: Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetesStudy flowchart. eGFR, estimated glomerular filtration rate; ALT, alanine transaminase; AST, aspartate transaminase; CVD, cardiovascular disease; FBG, fasting blood glucose; PPG, post-prandial glucose; HbA1c, glycated hemoglobin A1c; SGLT2i, sodium glucose co-transporter 2 inhibitorBack to article page